GlassScriptPhysician profile
Randy D Makovsky
NPI 1801861323
$3,038.36
in general payments reported to CMS, 2019-2025
21 companies · $454 in 2025
The $454 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $447 · 2020: $181 · 2021: $429 · 2022: $490 · 2023: $619 · 2024: $419 · 2025: $454.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,392 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,392.35 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $757.24 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $690.76 | 2019-2023 | Xtandi, Myrbetriq |
| Pfizer INC. | $229.42 | 2020-2024 | |
| Tolmar, INC. | $225.86 | 2023-2025 | Jatenzo |
| Urovant Sciences INC | $221.82 | 2021-2022 | |
| Ferring Pharmaceuticals INC. | $171.23 | 2019 | |
| Hollister Incorporated | $124.49 | 2019-2023 | Onli, Vapro Pocket |
| Myovant Sciences INC. | $93.97 | 2021-2022 | |
| Abbvie INC. | $88.82 | 2023-2025 | |
| Verity Pharmaceuticals INC. | $76.60 | 2025 | Trelstar, Tlando |
| Acerus Pharmaceuticals Corporation | $67.10 | 2021-2022 | |
| Antares Pharma, INC. | $53.14 | 2022-2025 | Xyosted |
| Coloplast Corp | $50.99 | 2023-2025 | Speedicath |
| Clarus Therapeutics INC. | $43.09 | 2021 | |
| Endo Pharmaceuticals INC. | $23.89 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abc Home Medical Supply, INC. | $23.83 | 2025 | |
| Axonics, INC. | $23.58 | 2021 | |
| Neotract INC. | $23.30 | 2020 | |
| Myriad Genetic Laboratories, INC. | $21.41 | 2022 | |
| Olympus America INC. | $14.73 | 2025 | Itind System |
| Blue Earth Diagnostics | $13.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randy Makovsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.